195 related articles for article (PubMed ID: 10082200)
21. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
[TBL] [Abstract][Full Text] [Related]
22. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.
Ohlstein EH; Nambi P; Hay DW; Gellai M; Brooks DP; Luengo J; Xiang JN; Elliott JD
J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of TA-0201, an endothelin receptor antagonist, with recombinant and human prostate endothelin receptors.
Takahashi M; Taniguchi T; Tanaka T; Kanamaru H; Okada K; Muramatsu I
Eur J Pharmacol; 2003 Apr; 467(1-3):185-9. PubMed ID: 12706473
[TBL] [Abstract][Full Text] [Related]
24. The effects of diminishing albumin binding to some Endothelin receptor antagonists.
Szczepankiewicz BG; Bal RB; von Geldern TW; Wu-Wong JR; Chiou WJ; Dixon DB; Opgenorth TJ; Hoffman DJ; Borre AJ; Marsh KC; Nguyen BN
Life Sci; 1998; 63(21):1905-12. PubMed ID: 9825768
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature.
Moreland S; McMullen D; Abboa-Offei B; Seymour A
Br J Pharmacol; 1994 Jun; 112(2):704-8. PubMed ID: 8075891
[TBL] [Abstract][Full Text] [Related]
26. Effect of a novel bifunctional endothelin receptor antagonist, IRL 3630A, on guinea pig respiratory mechanics.
Makatani M; Fujitani Y; Takimoto M; Oda K; Sasaki Y; Hori S; Inui T; Sakaki J; Okada T; Hoshiko K; Yamamura T
Eur J Pharmacol; 2000 Oct; 406(1):139-47. PubMed ID: 11011045
[TBL] [Abstract][Full Text] [Related]
27. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.
Ohlstein EH; Nambi P; Douglas SA; Edwards RM; Gellai M; Lago A; Leber JD; Cousins RD; Gao A; Frazee JS
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8052-6. PubMed ID: 8058755
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists.
Awane-Igata Y; Ikeda S; Watanabe T
Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758
[TBL] [Abstract][Full Text] [Related]
29. 'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effects.
Chiou WJ; Wessale JL; von Geldern T; Opgenorth TJ; Wu-Wong JR
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S48-52. PubMed ID: 11078333
[TBL] [Abstract][Full Text] [Related]
30. Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy.
Cullen JP; Bell D; Kelso EJ; McDermott BJ
Eur J Pharmacol; 2001 Apr; 417(3):157-68. PubMed ID: 11334846
[TBL] [Abstract][Full Text] [Related]
31. Characterization of endothelin receptors in the anesthetized ferret: a novel model for investigating the functional ET(B) receptor subtypes.
Krause SM; Nolan NA; Clayton FC; Walsh TF; Williams DL
J Cardiovasc Pharmacol; 1999 Sep; 34(3):359-67. PubMed ID: 10470993
[TBL] [Abstract][Full Text] [Related]
32. Antagonist activity of [Thr18,gamma-methylleucine19]endothelin-1 in human endothelin receptors.
Masuda Y; Sugo T; Kikuchi T; Satoh M; Fujisawa Y; Itoh Y; Wakimasu M; Ohtaki T
Eur J Pharmacol; 1997 May; 325(2-3):263-70. PubMed ID: 9163574
[TBL] [Abstract][Full Text] [Related]
33. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
McCulloch KM; Docherty C; MacLean MR
Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of the mixed ET(A)/ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release.
Martin C; Held HD; Uhlig S
Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):128-36. PubMed ID: 10961375
[TBL] [Abstract][Full Text] [Related]
35. Ca2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells.
Maxwell MJ; Goldie RG; Henry PJ
Br J Pharmacol; 1998 Dec; 125(8):1768-78. PubMed ID: 9886769
[TBL] [Abstract][Full Text] [Related]
36. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonists.
Jae HS; Winn M; von Geldern TW; Sorensen BK; Chiou WJ; Nguyen B; Marsh KC; Opgenorth TJ
J Med Chem; 2001 Nov; 44(23):3978-84. PubMed ID: 11689084
[TBL] [Abstract][Full Text] [Related]
37. Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.
Yuyama H; Noguchi Y; Fujimori A; Ukai M; Fujiyasu N; Ohtake A; Sato S; Sudoh K; Sasamata M; Miyata K
Eur J Pharmacol; 2004 Sep; 498(1-3):171-7. PubMed ID: 15363992
[TBL] [Abstract][Full Text] [Related]
38. Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist.
Murugesan N; Gu Z; Spergel S; Young M; Chen P; Mathur A; Leith L; Hermsmeier M; Liu EC; Zhang R; Bird E; Waldron T; Marino A; Koplowitz B; Humphreys WG; Chong S; Morrison RA; Webb ML; Moreland S; Trippodo N; Barrish JC
J Med Chem; 2003 Jan; 46(1):125-37. PubMed ID: 12502366
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
[TBL] [Abstract][Full Text] [Related]
40. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
Watts SW; Fink GD; Northcott CA; Galligan JJ
Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
